Developmental Delay clinical trials
17 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays
- Problem Behavior Assessment and Intervention in IDEA Part C Services
- Behavioral Parent Training to Address Early Childhood Disruptive Behavior Using the Helping Our Toddlers, Developing Our Children's Skills (HOT DOCS) Program and the Developing Our Children's Skills Kindergarten-5th Grade (DOCS K-5) Program
- Implementation of Naturalistic Developmental Behavioral Intervention (NDBI) Through Coaching Caregivers of Young Autistic Children
- Promoting Playfulness
- Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure
- Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder
- PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
- Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
- Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
- Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency
- Longitudinal Study of Neurogenetic Disorders
- The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
- Families Moving Forward Bridges: An Early Intervention for Infants and Toddlers With PAE With or At-risk for FASD
- Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
- School-based Support for Pre-school Aged Children With Developmental Disabilities and Delays
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Developmental Delay” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.